Stock Fundamentals

Company Information

Company Name
Evolus Inc
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
ISIN: US30052C1071
CIK: 0001570562
CUSIP: 30052C107
Currency: USD
Full Time Employees: 350
Phone: 949 284 4555
Fiscal Year End: December
IPO Date: Feb 08, 2018
Description:

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Address:

520 Newport Center Drive, Newport Beach, CA, United States, 92660

Directors & Officers

Name Title Year Born
Mr. David Moatazedi President, CEO & Director 1978
Ms. Tatjana Mitchell Chief Financial Officer NA
Dr. Rui Avelar C.CFP, Dip.SportMed, M.D. Chief Medical Officer and Head of Research & Development 1962
Mr. Nareg Sagherian Head of Global Investor Relations & Corporate Communications NA
Mr. Kurt Knab Senior Vice President of Sales NA
Ms. Jessica Novak Senior Vice President of Human Resources NA
Mr. Jeffrey J. Plumer Corporate Secretary NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 20, 2026 David Moatazedi N/A Sale 13.67K $4.75 $64.93K
Mar 20, 2026 Rui Avelar N/A Sale 3.12K $4.75 $14.82K
Mar 17, 2026 David Moatazedi N/A Sale 116.72K $4.89 $570.76K
Mar 17, 2026 Rui Avelar N/A Sale 30.00K $4.89 $146.68K
Dec 22, 2025 David Moatazedi N/A Sale 10.54K $7.15 $75.35K
Dec 22, 2025 Rui Avelar N/A Sale 2.26K $7.15 $16.17K
Aug 22, 2025 Tomoko Yamagishi-Dressler N/A Sale 5.72K $7.51 $42.97K
Aug 15, 2025 Brady Stewart N/A Purchase 30.00K $6.82 $204.60K
Jun 16, 2025 David Moatazedi N/A Sale 16.58K $9.89 $164.00K
Jun 13, 2025 David Moatazedi N/A Sale 111.32K $10.05 $1.12M
Jun 09, 2025 Albert G White III N/A Purchase 20.00K $9.45 $189.00K
May 13, 2025 Sandra Beaver N/A Sale 6.49K $10.02 $65.07K
May 12, 2025 David Moatazedi N/A Sale 15.79K $9.87 $155.82K
May 12, 2025 Rui Avelar N/A Sale 3.39K $9.87 $33.41K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Nantahala Capital Management, LLC 6.38M Mar 31, 2026 9.68% $0.96 9.56%
BlackRock Inc 4.29M Mar 31, 2026 6.51% $0.00 4.76%
Vanguard Group Inc 3.34M Dec 31, 2025 5.07% $0.00 -2.54%
BRAIDWELL LP 3.11M Mar 31, 2026 4.72% $0.43 0.00%
Frazier Life Sciences Management, L.P. 2.63M Mar 31, 2026 3.99% $0.28 0.00%
Vanguard Capital Management, LLC 2.47M Mar 31, 2026 3.75% $0.00 0.00%
Soleus Capital Management, L.P. 2.25M Mar 31, 2026 3.41% $0.37 109.85%
Stonepine Capital Management Llc 1.76M Mar 31, 2026 2.67% $2.90 7.81%
Millennium Management LLC 1.46M Mar 31, 2026 2.22% $0.00 -30.19%
Armistice Capital, LLC 1.40M Mar 31, 2026 2.12% $0.10 43.03%
Geode Capital Management, LLC 1.38M Mar 31, 2026 2.10% $0.00 -0.35%
State Street Corp 1.32M Mar 31, 2026 2.01% $0.00 -16.13%
Perceptive Advisors LLC 1.29M Mar 31, 2026 1.95% $0.10 0.00%
Rice Hall James & Associates, LLC 1.25M Mar 31, 2026 1.91% $0.29 8.79%
Pinnacle Associates Inc 1.16M Mar 31, 2026 1.76% $0.06 48.13%
The Goldman Sachs Group Inc 1.09M Mar 31, 2026 1.65% $0.00 209.74%
UBS Group AG 752.88K Mar 31, 2026 1.14% $0.00 -14.58%
Citadel Advisors Llc 696.63K Mar 31, 2026 1.06% $0.00 -49.49%
Soviero Asset Management, LP 680.37K Mar 31, 2026 1.03% $1.40 3.87%
AWH Capital, L.P. 625.00K Mar 31, 2026 0.95% $2.33 0.00%

Shares Statistics

Shares Outstanding: 65.85M
Shares Float: 50.04M
% Insiders: 1,468.30%
% Institutions: 7,004.20%
Short % Float: 9.32%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 1.67M 2.53% ▲ 0.00% Apr 30, 2026
2 iShares Russell 2000 ETF 1.33M 2.03% ▲ 0.93% May 29, 2026
3 Vanguard Institutional Extnd Mkt Idx Tr 748.07K 1.14% ▲ 0.68% Apr 30, 2026
4 Fidelity Small Cap Index 549.74K 0.83% ▲ 7.99% Mar 31, 2026
5 iShares Russell 2000 Growth ETF 451.01K 0.68% ▼ 0.65% May 29, 2026
6 Xtrackers MSCI World Swap ETF 1C 393.42K 0.60% ▼ 0.63% Dec 31, 2025
7 Fidelity Extended Market Index 382.05K 0.58% ▲ 48.53% Apr 30, 2026
8 State St Russell Sm/Mid Cp® Indx SL Cl I 365.85K 0.56% ▲ 0.00% May 31, 2026
9 Russell 2000 Equity Index Fund B 341.23K 0.52% ▼ 0.17% Dec 31, 2025
10 Schwab US Small-Cap ETF™ 309.04K 0.47% ▲ 0.07% May 30, 2026

Valuation Metrics

Enterprise Value: $558.31M
Trailing P/E: 0.00
Forward P/E: 61.35

Financial Highlights

Market Cap: $443.20M
EBITDA: $-23.15M
Book Value: $-0.44
Earnings/Share: $-0.66
Profit Margin: -14.39%
Operating Margin: -9.38%
ROA (TTM): -9.06%
ROE (TTM): -18,729.61%
Revenue (TTM): $301.79M
Revenue/Share (TTM): $4.65
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 6.70%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 1.90x -6.43x 1.10x -1.91x -6.60x
2024-12-31 2.40x 22.32x 0.98x -1.84x -4.93x
2023-12-31 2.33x -5.88x 1.11x -3.56x -2.91x
2022-12-31 2.17x 3.96x 0.90x -7.18x -1.36x
2021-12-31 3.10x 0.89x 0.68x -31.81x -1.86x
2020-12-31 0.71x -1.85x 1.35x -14.57x -0.93x
2019-12-31 6.23x 1.17x 0.67x -12.44x -1.01x
2018-12-31 17.88x 0.20x 0.51x -53.47x -0.37x
2017-12-31 0.34x -2.80x 1.50x N/A -18.36x
2016-12-31 0.00x -8.41x 1.09x N/A -3.04x
2015-12-31 0.08x 3.85x 0.85x N/A -1.51x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about EOLS.US!